Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.2619
+0.0072 (2.83%)
At close: Apr 9, 2026, 4:00 PM EDT
0.2706
+0.0087 (3.32%)
After-hours: Apr 9, 2026, 7:51 PM EDT
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $108.5 million as of April 9, 2026. Its market cap has decreased by -42.44% in one year.
Market Cap
108.50M
Enterprise Value
114.35M
1-Year Change
-42.44%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $108.50M, a decrease of -65.46%. That is a compound annual growth rate of -4.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 108.50M | -23.21% |
| Dec 31, 2025 | 141.30M | -33.60% |
| Dec 31, 2024 | 212.80M | 120.98% |
| Dec 29, 2023 | 96.30M | -81.29% |
| Dec 30, 2022 | 514.60M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | 2.21B | 127.45% |
| Dec 31, 2019 | 970.40M | -17.20% |
| Dec 31, 2018 | 1.17B | -15.45% |
| Dec 29, 2017 | 1.39B | 543.50% |
| Dec 30, 2016 | 215.40M | -66.32% |
| Dec 31, 2015 | 639.50M | -38.53% |
| Dec 31, 2014 | 1.04B | 21.20% |
| Dec 31, 2013 | 858.40M | 169.51% |
| Dec 31, 2012 | 318.50M | 113.76% |
| Dec 30, 2011 | 149.00M | -50.38% |
| Dec 31, 2010 | 300.30M | 12.98% |
| Dec 31, 2009 | 265.80M | 86.40% |
| Dec 31, 2008 | 142.60M | -72.71% |
| Dec 31, 2007 | 522.60M | 133.30% |
| Dec 29, 2006 | 224.00M | 118.75% |
| Dec 30, 2005 | 102.40M | -32.23% |
| Dec 31, 2004 | 151.10M | 11.35% |
| Dec 31, 2003 | 135.70M | 83.13% |
| Dec 31, 2002 | 74.10M | -67.54% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 118.61M |
| Genelux | 117.59M |
| PepGen | 115.42M |
| Kazia Therapeutics | 109.93M |
| LeonaBio | 109.72M |
| Cardiff Oncology | 106.65M |
| Oncolytics Biotech | 104.52M |
| Verrica Pharmaceuticals | 100.84M |